Telangana Pharma City secures a significant ₹5,260 crore investment from six top pharmaceutical companies, strengthening its position as a global hub for the pharmaceutical industry. This ambitious project will create 12,490 jobs, further boosting Telangana’s commitment to innovation and industrial growth.
Major investors driving Telangana Pharma City secure
Six pharmaceutical leaders—MSN Labs, Laurus Labs, Gland Pharma, Dr. Reddy’s Laboratories, Aurobindo Pharma, and Hetero Labs—have agreed to set up advanced manufacturing and research facilities in Pharma City. Their investments underscore Telangana’s growing appeal as a prime destination for pharmaceutical companies worldwide.
Investments and developments Telangana Pharma City secures
The companies plan to develop cutting-edge facilities in Pharma City. MSN Labs will build a manufacturing unit and R&D centre. Laurus Labs will establish a formulation unit dedicated to innovative drug development. Aurobindo Pharma will focus on producing high-quality medications.
Gland Pharma plans to set up production for injectables and advanced R&D facilities. Dr. Reddy’s Laboratories will build units specializing in biosimilars and injectables, catering to global markets. Hetero Labs will construct a plant for finished dose formulations and injectable manufacturing. These projects will significantly elevate Telangana Pharma City’s operational and research capacities.
Telangana government facilitates Pharma City’s growth
The Telangana government, under the leadership of Chief Minister K. Chandrashekar Rao and Industries Minister K.T. Rama Rao, actively supports the Pharma City project. Authorities are working to allocate land and expedite approvals to enable companies to begin construction within four months.
In a recent meeting, key industry leaders, including Satish Reddy from Dr. Reddy’s Labs and MSN Reddy from MSN Labs, discussed how their investments align with the state’s vision for industrial growth. This collaboration highlights the government’s proactive approach to promoting industrial development.
Telangana Pharma City secures economic growth and jobs
The ₹5,260 crore investment in Telangana Pharma City will create 12,490 direct jobs and provide opportunities for skilled professionals in the region. The initiative will also boost Telangana’s GDP and enhance India’s pharmaceutical exports, strengthening the state’s reputation as a global pharmaceutical hub.
Telangana Pharma City secures its role as a pharma powerhouse
Telangana Pharma City is a transformative project that offers world-class infrastructure, sustainable practices, and business-friendly policies. With strong government support and significant private investment, the project will become a cornerstone of India’s pharmaceutical and life sciences industries, driving innovation, employment, and economic growth.
